The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.
Cancer research • Vol. 61, Issue 7 • 2001
Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.
International journal of radiation oncology, biology, physics • Vol. 50, Issue 1 • 2001
Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.
Cancer research • Vol. 61, Issue 9 • 2001
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 7, Issue 5 • 2001
